We're all often guilty of it. Being so busy that we begin to rush. I often need to take a figurative and literal breath to remember why I – and I'm sure many of us – became pharmacists in the…

Boston-based Verve Therapeutics presented strong findings Nov. 12 for a gene therapy candidate aimed at disabling the gene linked to low-density lipoprotein cholesterol. 

Novo Nordisk will invest more than $6 billion to expand manufacturing facilities in Denmark, the company said Nov. 10. The facility will support increased production capacity for its GLP-1 drugs Ozempic and Wegovy, and other chronic disease treatments. 

Long-awaited findings from an international study of more than 17,000 patients showed the weight loss drug Wegovy reduced the risk of having a heart attack or stroke, and the risk of dying from a heart attack.

As applications for pharmacy schools and residency programs wither, hospital pharmacy leaders are warily preparing for a shortage of clinical pharmacists. 

Despite financial headwinds, the healthcare industry is plugging money and resources into home infusion service lines, according to Provident Healthcare Partners.

The FDA on Nov. 9 granted approval to Ixchiq, the first vaccine to protect against chikungunya virus. 

The chief medical officer of Walgreens Boots Alliance, Kevin Ban, MD, will exit his role as of Nov. 10, a spokesperson confirmed to Becker's.

Walgreens is planning to lay off about 5% of its corporate workforce, or 267 employees, the Chicago Tribune reported Nov. 9.

Hospital and health system pharmacy leaders might be missing out on big-picture goals in "emerging frontiers" as they extinguish long-standing issues, such as rising healthcare costs and a pharmacy technician shortage, according to an Oct. 7 article from McKinsey.